Fig. 7
From: ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
Relationship between ARHGAP39 expression and the abundance of immunomodulators in BRCA using TISIDB. A-B The correlation between ARHGAP39 expression and the abundance of MHC molecules and top 4 MHC molecules showing the greatest correlation with ARHGAP39 expression. B The correlation between ARHGAP39 expression and the abundance of immunostimulators and top 4 immunostimulators showing the greatest correlation with ARHGAP39 expression. C The correlation between ARHGAP39 expression and the abundance of immunoinhibitors and top 4 immunoinhibitors showing the greatest correlation with ARHGAP39 expression